Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-11 · accession 0001231589-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-12 | 2025-12-11 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +11.0K | 47.8K | +30% | +$1.61M |
| DMT | 2025-12-12 | 2025-12-11 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $484.67 | -11.0K | 38.3K | -22% | -$5.33M |
| DT | 2025-12-12 | 2025-12-11 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 20.2K | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-11 | M | A | 11,000 | $146.03 | 47,781 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-11 | S | D | 1,116 | $486.36 | 37,181 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $485.90 to $486.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-12-11 | S | D | 400 | $487.37 | 36,781 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $487.24 to $487.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-12-11 | S | D | 560 | $482.22 | 47,221 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $481.84 to $482.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-12-11 | S | D | 900 | $483.25 | 46,321 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $482.88 to $483.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-12-11 | S | D | 5,220 | $484.31 | 41,101 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $483.88 to $484.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2025-12-11 | S | D | 2,804 | $485.22 | 38,297 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $484.88 to $485.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Option | 2025-12-11 | M | D | 11,000 | $0.00 | 20,250 | D | $146.03 · 2020-03-15 to 2027-03-15 | 11,000 Common Stock |